Palomino Laboratories (PALX) Cash from Financing Activities (2023 - 2025)
Palomino Laboratories (PALX) posted Cash from Financing Activities of $8.1 million for Q3 2025, up 40604.23% sequentially from $19980.0 in Q2 2025, and up 40476.29% YoY from N/an in Q3 2024.
Palomino Laboratories (PALX) Cash from Financing Activities (2023 - 2025) Analysis & Trends
Palomino Laboratories has reported Cash from Financing Activities for 3 years, with the latest figure at $8.1 million in Q3 2025.
- Quarterly Cash from Financing Activities rose 40476.29% year-over-year to $8.1 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $8.3 million (changed N/A YoY) and the FY2024 annual result came in at $195437.0, up 146.58% from the prior year.
- Cash from Financing Activities grew to $8.1 million in Q3 2025 per PALX's latest filing, from $19980.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $8.1 million in Q3 2025 and troughed at $20.0 in Q1 2025.
- A 3-year average of $1.4 million and a median of $38404.5 in 2023 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities jumped 155.0% in 2024, then surged 40476.29% in 2025.
- Over 3 years, Cash from Financing Activities stood at $56766.0 in 2023, then surged by 155.0% to $144753.0 in 2024, then jumped by 5518.33% to $8.1 million in 2025.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $8.1 million, $19980.0, and $20.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 8.13 Mn |
| Sep 30, 2025 | 8.13 Mn |
| Jun 30, 2025 | 19,980.00 |
| Jun 30, 2025 | 19,980.00 |
| Mar 31, 2025 | 20.00 |
| Mar 31, 2025 | 20.00 |
| Dec 31, 2024 | 144,753.00 |
| Dec 31, 2024 | 144,753.00 |
| Sep 30, 2024 | 20,043.00 |
| Sep 30, 2024 | 20,043.00 |
| Dec 31, 2023 | 56,766.00 |
| Dec 31, 2023 | 56,766.00 |